Evaluating Safety & Efficacy of Apremilast in the Treatment of Cutaneous Disease in Patients With Recalcitrant Dermatomyositis
Clinical trial NCT03529955 · COMPLETED
Trial details
- NCT number
- NCT03529955
- Sponsor
- Tulane University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-06-12
- Primary completion
- 2021-02-28
- Enrollment
- 8
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.